Bernard Poussot Elected CEO of Wyeth - - BioPharm International

ADVERTISEMENT

Bernard Poussot Elected CEO of Wyeth

BioPharm Bulletin

Wyeth (Madison, NJ) has elected Bernard Poussot president and chief executive officer (CEO), effective January 1, 2008. Poussot began his career at Wyeth in 1986. In April 2006, Poussot was promoted to president and vice chairman of Wyeth, and in January 2007, he was promoted to president, chief operating officer, and vice chairman. Robert Essner, current chairman and CEO, will continue as chairman of the board of directors after his term as CEO ends at the end of 2007.

Wyeth’s release

blog comments powered by Disqus

ADVERTISEMENT

Cobra Biologics Announces Development Projects
June 14, 2013
Supreme Court: Human Genes Are Not Patentable
June 14, 2013
ISPE Study Reports on Root Causes for Drug Shortages
June 12, 2013
Elan Board Rejects Multibillion Takeover Bid from Royalty Pharma
June 11, 2013
EMA Revises Biosimilars Guideline
June 11, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm Bulletin,
Click here